Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study).
Pagani S, Lombardi N, Crescioli G, Vighi GV, Spada G, Romoli I, Andreetta P, Capuano A, Marrazzo E, Marra A, Leoni O, Vannacci A, Venegoni M, Vighi GD; MEREAFaPS Study group. Pagani S, et al. Among authors: vighi gv. Intern Emerg Med. 2021 Apr;16(3):741-748. doi: 10.1007/s11739-020-02521-x. Epub 2021 Jan 4. Intern Emerg Med. 2021. PMID: 33392971
Risk of Hospitalization for Adverse Drug Events in Women and Men: A Post Hoc Analysis of an Active Pharmacovigilance Study in Italian Emergency Departments.
Crescioli G, Boscia E, Bettiol A, Pagani S, Spada G, Vighi GV, Bonaiuti R, Venegoni M, Vighi GD, Vannacci A, Lombardi N, On Behalf Of The MEREAFaPS Study Group. Crescioli G, et al. Among authors: vighi gv. Pharmaceuticals (Basel). 2021 Jul 15;14(7):678. doi: 10.3390/ph14070678. Pharmaceuticals (Basel). 2021. PMID: 34358104 Free PMC article.
Italian Emergency Department Visits and Hospitalizations for Outpatients' Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study).
Lombardi N, Crescioli G, Bettiol A, Tuccori M, Capuano A, Bonaiuti R, Mugelli A, Venegoni M, Vighi GD, Vannacci A; MEREAFaPS Study group. Lombardi N, et al. Front Pharmacol. 2020 Apr 6;11:412. doi: 10.3389/fphar.2020.00412. eCollection 2020. Front Pharmacol. 2020. PMID: 32327995 Free PMC article.